|
Debra Peattie, PhD, MBA, is Managing Director of Pleiades Advisors, an advisory company that serves early and mid-stage life science companies. Previously, she was Co-Founder and Chief Technology Officer of Valeo Medical, a women’s health diagnostics company, and President of RCT BioVentures NE, a seed fund focused on early stage diagnostic and therapeutic technologies. Prior to that, she was a limited partner at MPM Capital, LP, where she helped raise and manage the firm’s initial $230 million fund, and a founding scientist of Vertex Pharmaceuticals. Recruited from a Harvard faculty position to join Vertex, Dr. Peattie established and directed the company’s molecular biology division for four years before joining the company’s business development group. Dr. Peattie received her PhD in biochemistry and molecular biology from Harvard University and an MBA from Harvard Business School. | 